课题基金 / 基金详情

(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS

(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
(PQ2) HIV 感染、APOBEC 上调和癌症突变
批准号:
9127434
负责人:
Reuben S Harris
金额:
$21.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-10 至 2018-04-30

项目摘要

项目成果

Reuben S Harris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The incidence of several types of cancer is higher in HIV-1 infected patients in comparison to the general population. Little is known about the mechanistic basis for these observations. This R21 proposal addresses RFA-CA-15-013 and, specifically, provocative question 2: "Other than immune dysfunction (including inflammation), what are the HIV-mediated mechanisms that underlie differential cancer risk in individuals with HIV infection?" We will use molecular virology and molecular biology approaches, together with bioinformatics, to investigate a mechanistic link between viral infection of CD4-positive T lymphocytes and a signaling mechanism that causes the trans-upregulation of antiviral APOBEC3 enzymes in bystander cells, leading to increased levels of genomic mutation that in turn result in a higher likelihood of cancer. The demonstration of such a mechanism would be a significant advance because it is novel and suggests multiple points for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Midwest AViDD Center
  • 批准号:
    10631659
  • 项目类别:
  • 资助金额:
    $45.68万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
Midwest AViDD Center
  • 批准号:
    10522804
  • 项目类别:
  • 资助金额:
    $6643.12万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
Administrative-Core-001
Project 3: Pandemic Virus Protease Inhibitors
  • 批准号:
    10522812
  • 项目类别:
  • 资助金额:
    $288.0万
  • 财政年份:
    2022
  • 负责人:
    Reuben S Harris
  • 依托单位:
海外基金